// App-Quantinova.ai

TCTAP A-136 : Primary Versus Tenecteplase-facilitated Percutaneous Coronary Intervention with Routine Thrombus Aspiration and Closing Device in Patients with STEMI

Researchers

Presenter

  • Ji Young Park

Principal Investigators

  • Jiyoung Park

  • Sungkee Rye

  • Seunghwan Kim

  • Kyngtae Jung

  • Youjeong Choi

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • Collagen type IV alpha 2 chain

Drug/Treatment

  • Tenecteplase

  • Clopidogrel bisulfate

  • Enoxaparin

  • Enoxaparin sodium

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved